In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia
- PMID: 11986239
- DOI: 10.1182/blood.v99.10.3801
In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia
Abstract
Recent reports have established the prenatal origin of leukemia translocations and resultant fusion genes in some patients, including MLL-AF4 translocations in infants and TEL-AML1 translocations in children. We now report evidence for the prenatal origin of a translocation in childhood acute myeloid leukemia (AML). The t(8;21) AML1-ETO translocations were sequenced at the genomic level in 10 diagnostic leukemia samples from children with available neonatal Guthrie blood spots. Clonotypic genomic AML1-ETO sequences were detected in the Guthrie spots for 5 individuals, providing unambiguous evidence of prenatal origin in these cases. Two of these patients were older than 10 years of age at diagnosis, indicative of a protracted postnatal latency. Three of the patients were assessed for the persistence of genomic fusion sequences in complete clinical remission samples and were found to be positive. These data indicate that t(8;21) in childhood AML can arise in utero, possibly as an initiating event in childhood AML, and may establish a long-lived or stable parental clone that requires additional secondary genetic alterations to cause leukemia.
Similar articles
-
Molecular characterization of genomic AML1-ETO fusions in childhood leukemia.Leukemia. 2001 Dec;15(12):1906-13. doi: 10.1038/sj.leu.2402318. Leukemia. 2001. PMID: 11753612
-
Prenatal origin of childhood AML occurs less frequently than in childhood ALL.BMC Cancer. 2006 Apr 21;6:100. doi: 10.1186/1471-2407-6-100. BMC Cancer. 2006. PMID: 16630339 Free PMC article.
-
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.Blood. 1996 Jun 1;87(11):4789-96. Blood. 1996. PMID: 8639850
-
The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.Haematologica. 1997 May-Jun;82(3):364-70. Haematologica. 1997. PMID: 9234595 Review.
-
The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).Leuk Lymphoma. 1994 Aug;14(5-6):353-62. doi: 10.3109/10428199409049690. Leuk Lymphoma. 1994. PMID: 7812194 Review.
Cited by
-
The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells.BMC Cancer. 2004 Aug 6;4:44. doi: 10.1186/1471-2407-4-44. BMC Cancer. 2004. PMID: 15298716 Free PMC article.
-
An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice.Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9506-11. doi: 10.1073/pnas.1531730100. Epub 2003 Jul 24. Proc Natl Acad Sci U S A. 2003. PMID: 12881486 Free PMC article.
-
Comprehensive mutational profiling of core binding factor acute myeloid leukemia.Blood. 2016 May 19;127(20):2451-9. doi: 10.1182/blood-2015-12-688705. Epub 2016 Mar 15. Blood. 2016. PMID: 26980726 Free PMC article.
-
RUNX1 Mutations in Inherited and Sporadic Leukemia.Front Cell Dev Biol. 2017 Dec 20;5:111. doi: 10.3389/fcell.2017.00111. eCollection 2017. Front Cell Dev Biol. 2017. PMID: 29326930 Free PMC article. Review.
-
Evolutionary trajectory of leukemic clones and its clinical implications.Haematologica. 2019 May;104(5):872-880. doi: 10.3324/haematol.2018.195289. Epub 2019 Apr 19. Haematologica. 2019. PMID: 31004016 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical